HEALTH CARE REIT, INC. UNDERWRITING AGREEMENTHealth Care • November 16th, 2010 • Health Care Reit Inc /De/ • Real estate investment trusts • New York
Contract Type FiledNovember 16th, 2010 Company Industry JurisdictionHealth Care REIT, Inc., a Delaware corporation (the “Company”), proposes to sell to the underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representatives (the “Representatives”), $450,000,000 aggregate principal amount of the Company’s 4.950% Notes due 2021 (the “Notes”), to be issued pursuant to the provisions of an indenture dated as of March 15, 2010, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”), as supplemented by a supplemental indenture thereto, to be dated as of November 16, 2010 (the indenture, as so supplemented, the “Indenture”).
HEALTH CARE REIT, INC. $250,000,000 Shares of Common Stock (par value $1.00 per share) EQUITY DISTRIBUTION AGREEMENTHealth Care • November 15th, 2010 • Health Care Reit Inc /De/ • Real estate investment trusts • New York
Contract Type FiledNovember 15th, 2010 Company Industry JurisdictionHealth Care REIT, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with [_____________] (the “Manager”), as follows:
HEALTH CARE REIT, INC. UNDERWRITING AGREEMENTHealth Care • March 15th, 2010 • Health Care Reit Inc /De/ • Real estate investment trusts • New York
Contract Type FiledMarch 15th, 2010 Company Industry JurisdictionHealth Care REIT, Inc., a Delaware corporation (the “Company”), proposes to sell to the underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representatives (the “Representatives”), $342,394,000 aggregate principal amount of the Company’s 3.00% Convertible Senior Notes due 2029 (the “Notes”), to be issued pursuant to the provisions of an indenture dated as of March 15, 2010, between the Company and The Bank of New York Trust Company, N.A., as trustee (the “Trustee”), as supplemented by a supplemental indenture thereto, to be dated as of March 15, 2010 (the indenture, as so supplemented, the “Indenture”).
HEALTH CARE AUTHORITY (HCA) 2006 – 2007 CONTRACT FOR BASIC HEALTH PLUS AND MATERNITY BENEFITS PROGRAM APPROVED AS TO FORM BY THE ATTORNEY GENERAL’S OFFICEHealth Care • May 10th, 2006 • Molina Healthcare Inc • Hospital & medical service plans • Washington
Contract Type FiledMay 10th, 2006 Company Industry Jurisdiction
Dr. William A. Carter Chairman and CEO Hemispherx Biopharma, Inc. JFK Boulevard Suite 660 Philadelphia, Pa 19103 Re: Agreement Between Armada Health Care, LLC and Hemispherx Biopharma, Inc. Dear Dr. Carter,Health Care • March 14th, 2014 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 14th, 2014 Company IndustryArmada Health Care would like to request an extension to the above mentioned contract through August 14, 2014 subject to the same terms and conditions currently in place.
HEALTH CARE REIT, INC. UNDERWRITING AGREEMENTHealth Care • July 20th, 2007 • Health Care Reit Inc /De/ • Real estate investment trusts • New York
Contract Type FiledJuly 20th, 2007 Company Industry JurisdictionHealth Care REIT, Inc., a Delaware corporation (the “Company”), proposes to sell to the underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representatives (the “Representatives”), $400,000,000 aggregate principal amount of the Company’s 4.75% Convertible Senior Notes due 2027 (the “Notes” and, such principal amount, the “Firm Notes”), to be issued pursuant to the provisions of an indenture dated as of November 20, 2006, between the Company and The Bank of New York Trust Company, N.A., as trustee (the “Trustee”), as supplemented by a supplemental indenture thereto, to be dated as of July 20, 2007 (the indenture, as so supplemented, the “Indenture”). In addition, solely for the purpose of covering over-allotments, the Company proposes to grant to the Underwriters the option to purchase from the Company up to $60,000,000 aggregate principal amount of Notes (the “Option Notes”) as set forth below.
ARMADAHealth Care • March 19th, 2015 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 19th, 2015 Company IndustryArmada Health Care and BioRidge Pharma would like to request an extension to the above mentioned contracts initially signed on August 15, 2011 and extended in 2012 and 2013 through August 14, 2014 subject to the same terms and conditions currently in place.
HEALTH CARE REIT, INC. $80,000,000 7.57% Notes due 2000Health Care • April 21st, 1997 • Health Care Reit Inc /De/ • Real estate investment trusts
Contract Type FiledApril 21st, 1997 Company Industry
HEALTH CARE REIT, INC. UNDERWRITING AGREEMENTHealth Care • March 29th, 2012 • Health Care Reit Inc /De/ • Real estate investment trusts • New York
Contract Type FiledMarch 29th, 2012 Company Industry JurisdictionHealth Care REIT, Inc., a Delaware corporation (the “Company”), proposes to sell to the underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representatives (the “Representatives”), $600,000,000 aggregate principal amount of the Company’s 4.125% Notes due 2019 (the “Notes”), to be issued pursuant to the provisions of an indenture dated as of March 15, 2010, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”), as supplemented by a supplemental indenture thereto, to be dated as of April 3, 2012 (the indenture, as so supplemented, the “Indenture”).
HEALTH CARE REIT, INC. UNDERWRITING AGREEMENTHealth Care • November 19th, 2014 • Health Care Reit Inc /De/ • Real estate investment trusts • New York
Contract Type FiledNovember 19th, 2014 Company Industry Jurisdiction
HEALTH CARE REIT, INC. Stock Option AgreementHealth Care • May 10th, 2007 • Health Care Reit Inc /De/ • Real estate investment trusts • Delaware
Contract Type FiledMay 10th, 2007 Company Industry JurisdictionTHIS AGREEMENT, dated December 20, 2006, between Health Care REIT, Inc., a Delaware corporation (the “Company”), and Daniel R. Loftus (the “Participant”), is made pursuant and subject to the provisions of the 2002 Stock Incentive Plan (the “Plan”) of Windrose Medical Properties Trust, a Maryland real estate investment trust (the “Trust”), a copy of which has been made available to the Participant. All capitalized terms used herein but not otherwise defined herein shall have the meanings ascribed to them in the Plan, except that references in the Plan to the “Company” shall mean “Health Care REIT, Inc., a Delaware corporation” and references to the “Common Stock” shall mean “the common stock, $1.00 par value per share, of Health Care REIT, Inc.”